Previous studies reported that both the accumulation of hepatic lipids [28] and chronic inflammation (pathogenesis of NAFLD) [38–40] could decrease the expression of SHBG. This evidence concerns the gene SHBG and metabolic dysfunction-associated steatotic liver disease.